Non-exclusive discount agreements for pharmaceutical products according to § 130a para. 8 SGB V
Non-exclusive discount agreements according to § 130a para. 8 SGB V: Contract start on 01.09.2026. All interested companies can join the agreement at any time under the same conditions (admission model). This agreement serves as a transitional arrangement until the start of exclusive contracts. For an initial report on 01.09.2026, signed contracts, declarations, and proofs must be submitted by 10.08.2026. Required documents: signed contract in duplicate, proof of pharmaceutical approval (AMIce database extract), signed self-declaration (Annex 3), list of contract-relevant PZN (Annex 4), self-declaration on EU regulation (Annex 5). Contract documents, participating health insurance funds, and revenues are available on the GWQ ServicePlus AG procurement portal.
CONTRACTING AUTHORITY
Name
GWQ ServicePlus AG
City
Düsseldorf
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
LOTS (8)
Nicht-exklusive Rabattvereinbarungen für Fusidinsäure (ATR) nach § 130a Abs. 8 SGB V
Nicht-exklusive Rabattvereinbarungen für Nitrofurantoin nach § 130a Abs. 8 SGB V
Nicht-exklusive Rabattvereinbarungen für Perindopril + Amlodipin + Indapamid nach § 130a Abs. 8 SGB V
Nicht-exklusive Rabattvereinbarungen für Nebivolol nach § 130a Abs. 8 SGB V
Nicht-exklusive Rabattvereinbarungen für Testosteron (GEL) nach § 130a Abs. 8 SGB V
Nicht-exklusive Rabattvereinbarungen für Testosteron 180mg (ILO) nach § 130a Abs. 8 SGB V
Nicht-exklusive Rabattvereinbarungen für Thalidomid nach § 130a Abs. 8 SGB V
Nicht-exklusive Rabattvereinbarungen für Teduglutid nach § 130a Abs. 8 SGB V
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
not-allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
656 days remaining(LOT-0001)
Published